Managing Nasopharyngeal Carcinoma: Current and Future Directions
Author Information
Author(s): Agulnik M, Siu L L
Primary Institution: Princess Margaret Hospital, University Health Network
Hypothesis
Does the addition of chemotherapy to radiotherapy improve treatment outcomes for patients with locally advanced nasopharyngeal carcinoma?
Conclusion
Adding chemotherapy to radiotherapy significantly improves survival rates for patients with locally advanced nasopharyngeal carcinoma.
Supporting Evidence
- Approximately 70% of patients with newly diagnosed NPC present with locally advanced disease.
- Phase III clinical trials support the addition of chemotherapy to radiotherapy for the initial treatment of these patients.
- Chemotherapy compliance rates differ dramatically depending on the timing of therapy.
Takeaway
This study shows that giving chemotherapy along with radiation helps people with a type of throat cancer called nasopharyngeal carcinoma live longer and healthier.
Methodology
The review analyzed 13 randomized clinical trials comparing chemotherapy with radiotherapy to radiotherapy alone in patients with locally advanced nasopharyngeal carcinoma.
Potential Biases
Potential publication bias due to the exclusion of non-English studies.
Limitations
The review is limited to studies published in English and may not encompass all relevant research.
Participant Demographics
Patients primarily had locally advanced, nonmetastatic stage III or IV nasopharyngeal carcinoma.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website